Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
Funds further development and rigorous technical validation of a cancer research technology that has already cleared basic feasibility.
A tool that works once, in the hands of the team that built it, is not the same as a tool other labs can pick up and trust. This funds the gap between those two things — for technology that has already cleared NCI's own feasibility bar, typically through earlier work funded under a companion early-stage mechanism.
The bar to enter is stated plainly: major feasibility gaps have to be overcome alre…
Further development, enhancement and rigorous technical validation of a cancer research technology — molecular and cellular analysis platforms, multi-omic and spatial profiling, imaging and sensing, immuno-engineering, or biospecimen processing — where major feasibility gaps are already overcome with supportive preliminary data, aimed at adoption by the research community. Existing technology applied only to a new clinical target does not qualify.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up